Search Results | Showing 41 - 50 of 12633 results for "Company" |
| | | ... preparation materials, portfolio summaries and first-draft client communications directly from consolidated client data. The company said firms retain full control over access through existing HeirWealth permission settings and consent models, with client ... |
| | | | ... services licence (AFSL) of contracts for difference (CFD) issuer Trive Financial Services Australia, after determining the company was no longer carrying on a financial services business in Australia. The licence cancellation took effect on July 1 and ... |
| | | | ... including head of service partnerships and readiness. Further, Perryman was also employed at Qualitas Group, The Myer Family Company, Perennial Investment Partners, AllianceBernstein, HSBC, and more. Welcoming both appointees, Robb said the firm is taking ... |
| | | | ... increased its fully franked interim dividend after it delivered a 20.1% total shareholder return over the past year. The company lifted its interim dividend to 3.8 cents per share, fully franked, taking the annualised payout to 7.6 cents per share, a ... |
| | | | The long-serving chief executive of BNP Paribas Asset Management's local business has left the company. After leading BNP AM's Australia and New Zealand operations for more than 14 years, David Grybas is no longer with the company. BNP Paribas ... |
| | | | ... acquisition, through the BPEA EQT Mid-Market Growth Partnership, will see EQT partner with Orikan's management team as the company enters its next phase of growth. Financial terms of the transaction were not disclosed. Founded in Melbourne, Orikan provides ... |
| | | | ASIC has published its first comprehensive review of voluntary administration (VAs) and deeds of company arrangement (DOCAs). The review found the restructuring process continues to play an important role for larger and more complex businesses, while ... |
| | | | ... upfront cash payment of US$1.1 billion ($1.6bn) plus potential milestone payments. Myricx Bio is a UK-headquartered oncology company, developing novel class of payloads in cancer therapy for antibody-drug conjugates (ADCs). Brandon Capital was one of ... |
| | | | ... Asset Management global chief operating officer Darren Johnson said the platform will continue to steer growth for the company moving forward. "As we continue to grow and deepen our offering, having a modern, governed data platform is essential - both ... |
| | | | ... long-term growth through identification and management of leading assets across major emerging innovation themes, whether a company is private or public. The fund holds between 25 and 50 companies, some of which include Anthropic and prediction market ... |
|